Physician profile
Whitney Dixon
NPI 1477655447
$1,746.31
in general payments reported to CMS, 2019-2025
14 companies · $34.78 in 2025
The $34.78 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $27.26 · 2021: $310 · 2022: $475 · 2023: $580 · 2024: $136 · 2025: $34.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $552 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $551.53 |
| Education | $199.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,119.58 | 2019-2025 | Ubrelvy, Qulipta |
| Astellas Pharma US INC | $219.54 | 2023 | Veozah |
| Urovant Sciences INC | $79.21 | 2022 | |
| Amag Pharmaceuticals, INC. | $57.08 | 2019 | |
| Sumitomo Pharma America, INC. | $41.75 | 2023 | Myfembree |
| Pfizer INC. | $39.25 | 2023 | |
| Mycovia Pharmaceuticals, INC. | $35.12 | 2023 | Vivjoa |
| Therapeuticsmd, INC. | $32.87 | 2019 | |
| Lilly USA, LLC | $27.26 | 2020 | |
| Exact Sciences Corporation | $24.04 | 2023 | Cologuard Collection Kit |
| Organon LLC | $20.90 | 2023 | Nexplanon |
| Mayne Pharma Commercial LLC | $20.62 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $16.48 | 2022 | |
| Allergan, INC. | $12.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Dixon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.